Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ACIXF market cap is 20.2M. The company's latest EPS is SEK -0.0898 and P/E is -0.33.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Revenue | 2.17M | 3.76M | 5.82M | 6.24M | 6.2M |
| Operating Income | -41.43M | -51.7M | -76.48M | -77.55M | -66.37M |
| Net Income | -41.5M | -51.73M | -76.99M | -77.84M | -66.19M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Assets | 89.95M | 118.6M | 69.48M | 62.88M | 80.76M |
| Total Liabilities | 7.81M | 18.06M | 17.66M | 11M | 5.06M |
| Total Equity | 82.14M | 100.54M | 51.83M | 51.89M | 75.7M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Operating | -36.69M | -48.01M | -74.87M | -81.37M | -63.33M |
| Investing | N/A | -43k | -151k | N/A | -920k |
| Financing | 47.35M | -163k | 69.03M | 106.23M | 86.98M |
| Market Cap | 20.2M |
| Price to Earnings Ratio | -0.33 |
| Price to Sales Ratio | 3.57 |
| Price to Cash Ratio | 0.38 |
| Price to Book Ratio | 0.29 |
| Dividend Yield | - |
| Shares Outstanding | 737.19M |
| Average Volume (1 week) | 152k |
| Average Volume (1 Month) | 464.24k |
| 52 Week Change | 1.86% |
| 52 Week High | 0.07 |
| 52 Week Low | 0.018 |
| Spread (Intraday) | 768.5k (100%) |
| Company Name | Acarix AB (QB) |
| Address |
jungmansgatan 12 malmo 211 19 |
| Website | https://www.acarix.com |
| Industry | med, dental, hosp eq-whsl (5047) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
